查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1764139

細胞分離市場－全球產業規模、佔有率、趨勢、機會和預測（按細胞類型、應用、地區和競爭細分，2020-2030 年）

Cell Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cell Type, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年，全球細胞分離市場規模為34.7億美元，預計2030年將達到47.6億美元，複合年成長率為5.62%。細胞分離是指從混合細胞群分離特定類型細胞的過程，是再生醫學、癌症研究、免疫療法和幹細胞生物學等領域的基礎。隨著生命科學領域的發展，對高純度和活細胞的需求推動了對能夠提高細胞分離精度、可擴展性和效率的技術的投資增加。

市場概覽
預測期 2026-2030
2024年市場規模 34.7億美元
2030年市場規模 47.6億美元
2025-2030 年複合年成長率 5.62%
成長最快的領域 人類細胞
最大的市場 北美洲

個人化醫療的日益普及是主要的成長動力，這種醫療依賴分離患者特異性細胞以開發標靶療法。這種需求在腫瘤學領域尤其突出，因為免疫療法和細胞療法需要精準的細胞篩選。儘管高昂的成本和技術障礙構成挑戰——尤其是在分離稀有或脆弱細胞類型方面——但亞太地區新興市場正在創造新的擴張機會，這得益於醫療基礎設施、研究能力和製藥製造領域不斷成長的投資。

關鍵市場促進因素

醫療保健產業的成長

主要市場挑戰

細胞分離技術成本高昂

主要市場趨勢

對細胞療法的需求增加

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球細胞分離市場的影響

第5章：全球細胞分離市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依細胞類型（人類細胞、動物細胞）
    • 按應用（生物分子分離、癌症研究、幹細胞研究、體外診斷、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美細胞分離市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲細胞分離市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太細胞分離市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美細胞分離市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲細胞分離市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：全球細胞分離市場：SWOT 分析

第 15 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 16 章：競爭格局

  • Becton, Dickinson & Company
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Terumo Corporation
  • PluriSelect Life Science UG & Co. KG
  • Danaher Corporation
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences Inc.

第 17 章：策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 5108

The Global Cell Isolation Market was valued at USD 3.47 billion in 2024 and is projected to reach USD 4.76 billion by 2030, expanding at a CAGR of 5.62%. Cell isolation-the process of separating specific cell types from a mixed population-is fundamental in fields such as regenerative medicine, cancer research, immunotherapy, and stem cell biology. As the life sciences sector advances, the demand for high-purity and viable cells is driving increased investment in technologies that offer enhanced precision, scalability, and efficiency in cell separation.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.47 Billion
Market Size 2030USD 4.76 Billion
CAGR 2025-20305.62%
Fastest Growing SegmentHuman Cells
Largest MarketNorth America

A primary growth driver is the growing adoption of personalized medicine, which depends on isolating patient-specific cells for the development of targeted therapies. This need is particularly prominent in oncology, where immunotherapies and cell-based treatments require accurate cell selection. While high costs and technical barriers pose challenges-especially in isolating rare or delicate cell types-emerging markets in the Asia-Pacific region are creating new opportunities for expansion, supported by growing investments in healthcare infrastructure, research capabilities, and pharmaceutical manufacturing.

Key Market Drivers

Growth in Healthcare Industry

The expansion of the global healthcare industry is a central factor driving the growth of the cell isolation market. With annual revenues exceeding USD 4 trillion, healthcare is supported by key sectors such as pharmaceuticals and biotechnology, contributing nearly USD 850 billion, and medical technology and diagnostics, which account for over USD 400 billion. This industry growth-especially in emerging economies-is accelerating the adoption of advanced diagnostic and therapeutic tools, including cell-based solutions.

As hospitals, laboratories, and pharmaceutical firms increasingly invest in regenerative therapies and precision medicine, the demand for scalable and reliable cell isolation techniques is rising. Additionally, the increasing global prevalence of chronic illnesses, including cancer and autoimmune diseases, has intensified the need for targeted therapies. In 2021, noncommunicable diseases were responsible for over 43 million deaths globally, with the majority occurring prematurely in low- and middle-income countries-reinforcing the importance of cell-based technologies for future treatment protocols.

Key Market Challenges

High Cost of Cell Isolation Technologies

The high cost associated with cell isolation technologies continues to be a major limitation for broader adoption, particularly in resource-limited settings. Systems like fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS) require sophisticated instruments, proprietary reagents, and specialized personnel, all contributing to significant operational costs.

These expenses present a substantial barrier for smaller laboratories, academic institutions, and biotech startups. Moreover, ongoing costs-such as maintenance, consumables, and technical support-can hinder the full utilization of cell isolation tools, especially in developing countries where funding and access to infrastructure are limited.

Key Market Trends

Increased Demand for Cell-Based Therapies

A key trend influencing the cell isolation market is the rising demand for cell-based therapies. By 2035, treatments such as CAR-T, TCR, and TIL therapies are expected to make up over 45% of clinical demand for cell therapy products. These therapies are gaining traction for their ability to address a wide array of diseases, including cancer, autoimmune conditions, and degenerative disorders.

This shift toward cell-based interventions is driving the need for robust isolation technologies that can reliably deliver high-quality, contamination-free, and functional cells. As the industry focuses more on precision medicine, the development and clinical use of cell therapies require advanced systems capable of delivering consistent and reproducible results in complex workflows.

Key Market Players

  • Becton, Dickinson & Company
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Terumo Corporation
  • PluriSelect Life Science UG & Co. KG
  • Danaher Corporation
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences Inc.

Report Scope

In this report, the Global Cell Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Isolation Market, By Cell Type:

  • Human Cells
  • Animal Cells

Cell Isolation Market, By Application:

  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • In Vitro Diagnostics
  • Others

Cell Isolation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Isolation Market.

Available Customizations

Global Cell Isolation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Cell Isolation Market

5. Global Cell Isolation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Cell Type (Human Cells, Animal Cells)
    • 5.2.2. By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Cell Isolation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Cell Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Isolation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Cell Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Cell Isolation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Cell Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Cell Isolation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Cell Type
        • 6.3.3.2.2. By Application

7. Europe Cell Isolation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Cell Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Cell Isolation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Cell Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Cell Isolation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Cell Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Cell Isolation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Cell Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Cell Isolation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Cell Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Cell Isolation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Cell Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Cell Isolation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Cell Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cell Isolation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Cell Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Cell Isolation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Cell Type
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Cell Isolation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Cell Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Cell Isolation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Cell Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Cell Isolation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Cell Type
        • 8.3.5.2.2. By Application

9. South America Cell Isolation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Cell Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cell Isolation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Cell Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Cell Isolation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Cell Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Cell Isolation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Cell Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Cell Isolation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Cell Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cell Isolation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Cell Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Cell Isolation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Cell Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Cell Isolation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Cell Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Cell Isolation Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Becton, Dickinson & Company
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Merck KGaA
  • 16.3. Thermo Fisher Scientific Inc.
  • 16.4. Bio-Rad Laboratories Inc.
  • 16.5. Terumo Corporation
  • 16.6. PluriSelect Life Science UG & Co. KG
  • 16.7. Danaher Corporation
  • 16.8. STEMCELL Technologies Inc.
  • 16.9. Corning Inc.
  • 16.10. Akadeum Life Sciences Inc.

17. Strategic Recommendations

18. About Us & Disclaimer